研究者
J-GLOBAL ID：202401005242909361
更新日: 2024年10月25日
徳丸 碧海
トクマル カイ | Tokumaru Kai
論文 (8件)：
-
Kai Tokumaru, Tadashi Imafuku, Takao Satoh, Tomoaki Inazumi, Shu Hirashima, Ayano Nishinoiri, Taisei Nagasaki, Hitoshi Maeda, Yukihiko Sugimoto, Motoko Tanaka, et al. Omega 3 Fatty Acids Attenuate the Acute Kidney Injury to CKD Transition and Renal Fibrosis. Kidney360. 2024
-
Nanaka Arimura, Hiroshi Watanabe, Hiromasa Kato, Tadashi Imafuku, Takehiro Nakano, Miyu Sueyoshi, Mayuko Chikamatsu, Kai Tokumaru, Taisei Nagasaki, Hitoshi Maeda, et al. Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation. Toxins. 2023. 15. 3. 179-179
-
Takehiro Nakano, Hiroshi Watanabe, Tadashi Imafuku, Kai Tokumaru, Issei Fujita, Nanaka Arimura, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Masafumi Fukagawa, et al. Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway. Toxins. 2021. 13. 12. 909-909
-
Hiromasa Kato, Hiroshi Watanabe, Tadashi Imafuku, Nanaka Arimura, Issei Fujita, Isamu Noguchi, Shoma Tanaka, Takehiro Nakano, Kai Tokumaru, Yuki Enoki, et al. Advanced oxidation protein products contribute to chronic kidney disease-induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway. Journal of Cachexia, Sarcopenia and Muscle. 2021. 12. 6. 1832-1847
-
Kento Nishida, Hiroshi Watanabe, Ryota Murata, Kai Tokumaru, Rui Fujimura, Shun Oshiro, Taisei Nagasaki, Masako Miyahisa, Yuto Hiramoto, Hiroto Nosaki, et al. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation. International Journal of Molecular Sciences. 2021. 22. 11. 5600-5600
もっと見る
講演・口頭発表等 (7件)：
-
シスプラチン誘発急性腎障害に対するω3系脂肪酸の腎保護効果
(第67回日本腎臓学会 2024)
-
Omega 3 fatty acids attenuated AKI to CKD transition and renal fibrosis: Identification of anti-fibrotic metabolites
(ASN Kidney Week 2023 2023)
-
AKI to CKDに対するω3系脂肪酸の有効性と脂肪酸活性代謝物の同定
(第65回日本脂質生化学会 2023)
-
AKI to CKDに対するω3系脂肪酸の有効性と脂肪酸活性代謝物の同定
(第38回日本薬学会九州山口支部大会 2021)
-
AKI to CKD transition抑制効果に関与するω3系脂肪酸代謝物の同定
(第64回日本腎臓学会)
もっと見る
学歴 (1件)：
- 2022 - 現在 熊本大学 薬学教育部 医療薬学専攻
学位 (1件)：
前のページに戻る
